Postbiotics in Gut Health and Disease

Postbiotics are defined as preparations of inactivated microorganisms and/or their components that confer measurable health benefits on the host. Unlike live probiotics, postbiotics comprise microbial cell fragments, metabolites and secreted proteins without viable cells, combining safety advantages with retained bioactivity. Key mechanisms include modulation of intestinal barrier integrity, regulation of mucosal and systemic immune responses, and inhibition of pathogen colonisation. Principal bioactive constituents encompass short-chain fatty acids, extracellular polysaccharides, peptidoglycan fragments, surface layer proteins and secreted peptides. These molecules interact with host pattern recognition receptors to fine-tune inflammatory pathways, enhance epithelial tight junctions and promote microbial homeostasis. Emerging evidence links postbiotics to improvements in functional gastrointestinal disorders, prevention of infectious colitis, attenuation of inflammatory bowel disease activity and support for neonatal gut maturation. Industrial and regulatory interest is rising as standardised definitions and production methods pave the way for novel therapeutic and nutritional applications across human and veterinary medicine.

Research from Nature Portfolio

Recent studies have established a clear, consensus-based definition of postbiotics, laying the groundwork for consistent research and regulation. This foundational work emphasises the requirement for inanimate microbial cells or cell components, with or without derived metabolites, to be present in the preparation. Investigators have delineated categories of bioactive compounds, characterised mechanisms of action—such as modulation of Toll-like receptor signalling and enhancement of mucin expression—and proposed minimum evidence thresholds for health claims. The consensus has already influenced product development, guiding safety assessments and encouraging innovation in functional formulations targeting gut barrier function and immune modulation.

Postbiotics in Gut Health and Disease publication trend

The graph below shows the total number of articles in postbiotics in gut health and disease across all publications each year (not limited to Nature Index journals).

Technical terms

Postbiotics: Preparations of inactivated microorganisms and/or their components that confer a health benefit on the host.

Paraprobiotics: Inactivated microbial cells or cell fragments that, without live organisms, may exert health-promoting effects.

Short-chain fatty acids (SCFAs): Metabolic end products of microbial fermentation, such as acetate, propionate and butyrate, involved in gut barrier support and immunoregulation.

Pattern Recognition Receptors (PRRs): Host cell receptors that detect conserved microbial molecules (MAMPs) and initiate innate immune signalling.

References

1. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology (2021).
2. Probiotic Cell‐Free Supernatants Exhibited Anti‐Inflammatory and Antioxidant Activity on Human Gut Epithelial Cells and Macrophages Stimulated with LPS. Evidence-based Complementary and Alternative Medicine (2018).
3. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microbial Cell Factories (2020).
4. Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond. International Journal of Molecular Sciences (2019).